Business development to date shows an increasing capacity utilization in the clinics

The demand for non-corona-induced medical and therapeutic measures has been increasing since mid-2021

12:40 pm: Ad hoc-Publication of inside information in acc. with Article 17 of Regulation (EU) No 596/2014: Changes in the Management Board of MEDICLIN Aktiengesellschaft

Dr. Joachim Ramming becomes the new CEO of MEDICLIN

MEDICLIN focuses on patient safety and innovative concepts in rehabilitation

The effects of the coronavirus pandemic are burdening the business development in the first quarter of 2021

MEDICLIN AG: Massive loss of earnings due to corona pandemic – outlook 2021 afflicted with uncertainties – effective protective shield is necessary.

MEDICLIN has achieved the revised targets for 2020

The Board of Management of MEDICLIN will be expanded − Dr. York Dhein will join on April 1st, 2021

3 pm: Ad hoc-Release Disclosure of an inside information acc. to Article17 MAR of the Regulation (EU) No 596/2014: MEDICLIN publishes forecast for fiscal year 2020